country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-181449

Copy Link Print Information

CAY10729

CAY10729 (Compound 21) is a selective PAD2 inhibitor. CAY10729 inhibits neutrophil extracellular trap formation.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No.: 1644666-57-8
Formule: C₁₉H₂₆ClN₇O₃
Masse moléculaire:435.91

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

CAY10729 Chemical Structure

CAS No.: 1644666-57-8

Size

Prix

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- IC₅₀ & Target
- Cellular Effect
- In Vitro
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

CAY10729 (Compound 21) is a selective PAD2 inhibitor. CAY10729 inhibits neutrophil extracellular trap formation^[1].

IC₅₀ & Target^[1]

PAD2

Cellular Effect

Cell Line	Type	Value	Description	References
Neutrophil	EC₅₀	985 μM Compound: 21	Cytotoxicity against human neutrophils assessed as cell viability after 4 hrs by XTT assay Cytotoxicity against human neutrophils assessed as cell viability after 4 hrs by XTT assay	[PMID: 25559347]

In Vitro

CAY10729 (1-500 μM; 4 h) exhibits extremely low cytotoxicity toward neutrophils, with an EC₅₀ of 985 μM^[1].
CAY10729 (200 mM) inhibits neutrophil extracellular trap formation^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

Human osteosarcoma (U2OS) cells
Concentration:

20 μM
Incubation Time:

72 h
Result:

Showed no reduction in U2OS cell viability relative to DMSO-treated controls.

Chemical Information

CAS No. 1644666-57-8
Masse moléculaire 435.91
Formule C₁₉H₂₆ClN₇O₃
SMILES

O=C(C1=C(C=CC=C1)C(O)=O)N[C@H](C2=NN(N=N2)C(C)(C)C)CCCNC(CCl)=N
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Instruction de manipulation (2659 KB)

Références

[1]. Subramanian V, et al. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors. J Med Chem. 2015;58(3):1337-1344. [Content Brief]

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Obtenir un devis En stock

Other size

Obtenir un devis